Jasmyn E. A. Cunningham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jasmyn E. A. Cunningham has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Abraham Nunes
Dalhousie University
6 shared publications - Selena Singh
Department of Psychology, Neuroscience and Behaviour, McMaster University, Hamilton, Canada
3 shared publications Suzanna Becker
3 shared publications- Colin M. Shapiro
University of Toronto, Sleep and Alertness Clinic Toronto
2 shared publications - Jay Toulany
Department of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 2E2, Canada
2 shared publications Martin Alda
Department of Psychiatry Dalhousie University Halifax Nova Scotia Canada
2 shared publications
Latest Publications
- Open Access
- 22 March 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 185, 106652
The conceptualization, measurement, and critical appraisal of computational models of anhedonia in depression
- 22 March 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 185, 106652
Open AccessThe conceptualization, measurement, and critical appraisal of computational models of anhedonia in depression
- Open Access
- 3 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (11) , 1662
Overlap and Divergence in Ketamine and Lithium Response in Bipolar Disorder: A Scoping Review
Background/Objectives: Lithium remains the first choice for long-term prophylaxis of mood episodes in bipolar disorder (BD), but only 30% of patients will respond, and there is no reliable method by which to predict treatment response. Ketamine is a rapid antidepressant therapy which ostensibly yields greater results in patients with clinical phenotypes that are classically associated with lithium non-response. This inspired a scoping review to map the overlapping and divergent clinical and mechanistic evidence for acute ketamine response and long-term prophylactic lithium therapy in BD. Methods: We conducted a scoping review of clinical and preclinical studies that examine convergent and divergent predictors and mechanisms of acute response to ketamine and long-term response to lithium. Results: Data from 19 preclinical studies show mechanistic convergence of ketamine and lithium on the GSK-3β/mTOR pathways, and enhancement of synaptic plasticity. Furthermore, lithium appears to consistently limit ketamine-related oxidative stress and hyperlocomotion. However, data from the 23 clinical studies suggest divergence of predictors of response to ketamine and lithium in BD, with ketamine response associated with metabolic risk factors, anxiety/mixed features, and non-melancholic presentations, which are generally predictors of poorer prophylactic lithium response. No study directly tested ketamine response as a predictor of prophylactic lithium response. An important limitation is that clinical studies of ketamine are enriched for lithium-refractory populations and have often included mixed unipolar and bipolar cases. Conclusions: Overall, existing data support mechanistic overlap but clinical divergence between ketamine and lithium responders, though this is confounded by sampling bias. We must therefore undertake longitudinal studies of prophylactic lithium therapy among patients with BD who received ketamine for acute antidepressant treatment in order to investigate if responsiveness to ketamine predicts response to lithium, and establish control over BD earlier in the course of illness.
- 3 November 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (11) , 1662
Open AccessOverlap and Divergence in Ketamine and Lithium Response in Bipolar Disorder: A Scoping Review
Background/Objectives: Lithium remains the first choice for long-term prophylaxis of mood episodes in bipolar disorder (BD), but only 30% of patients will respond, and there is no reliable method by which to predict treatment response. Ketamine is a rapid antidepressant therapy which ostensibly yields greater results in patients with clinical phenotypes that are classically associated with lithium non-response. This inspired a scoping review to map the overlapping and divergent clinical and mechanistic evidence for acute ketamine response and long-term prophylactic lithium therapy in BD. Methods: We conducted a scoping review of clinical and preclinical studies that examine convergent and divergent predictors and mechanisms of acute response to ketamine and long-term response to lithium. Results: Data from 19 preclinical studies show mechanistic convergence of ketamine and lithium on the GSK-3β/mTOR pathways, and enhancement of synaptic plasticity. Furthermore, lithium appears to consistently limit ketamine-related oxidative stress and hyperlocomotion. However, data from the 23 clinical studies suggest divergence of predictors of response to ketamine and lithium in BD, with ketamine response associated with metabolic risk factors, anxiety/mixed features, and non-melancholic presentations, which are generally predictors of poorer prophylactic lithium response. No study directly tested ketamine response as a predictor of prophylactic lithium response. An important limitation is that clinical studies of ketamine are enriched for lithium-refractory populations and have often included mixed unipolar and bipolar cases. Conclusions: Overall, existing data support mechanistic overlap but clinical divergence between ketamine and lithium responders, though this is confounded by sampling bias. We must therefore undertake longitudinal studies of prophylactic lithium therapy among patients with BD who received ketamine for acute antidepressant treatment in order to investigate if responsiveness to ketamine predicts response to lithium, and establish control over BD earlier in the course of illness.
- Open Access
- 29 September 2025
- Published by MDPI AG in Preprints.org
Prediction of Prophylactic Response to Lithium in Bipolar Disorder Using Acute Antidepressant Non-Response to Ketamine: A Scoping Review
Lithium remains the first choice for long-term prophylaxis of mood episodes in bipolar disorder (BD), but only 30% of patients will respond, and there is no reliable method by which to predict treatment response. Ketamine is a rapid antidepressant therapy which ostensibly yields greater results in patients with clinical phenotypes that are classically associated with lithium non-response. Thus, we hypothesized an inverse relationship between acute ketamine response and efficacy of long-term prophylactic lithium therapy in BD. We conducted a scoping review of clinical and preclinical studies that examine convergent and divergent predictors and mechanisms of acute response to ketamine and long-term response to lithium. Preclinical data show mechanistic convergence of ketamine and lithium on the GSK-3β/mTOR pathways, and enhancement of synaptic plasticity. Furthermore, lithium appears to consistently limit ketamine-related oxidative stress and hyperlocomotion. However, clinical predictors diverge, with ketamine response associated with metabolic risk factors, anxiety/mixed features, and non-melancholic presentations, which are generally predictors of poorer prophylactic lithium response. No study directly tested ketamine response as a predictor of prophylactic lithium response. An important limitation is that clinical studies of ketamine are enriched for lithium-refractory populations and have often included mixed unipolar and bipolar cases. Overall, existing data support mechanistic overlap but clinical divergence between ketamine and lithium responders, which is only partially consistent with our hypothesized inverse relationship. We must therefore undertake longitudinal studies of prophylactic lithium therapy among patients with BD who received ketamine for acute antidepressant treatment. If this inverse relationship is validated, ketamine non-response could be used to rapidly identify lithium-responsive BD, thereby establishing control over this disease earlier in the course of illness.
- 29 September 2025
- Published by MDPI AG in Preprints.org
Open AccessPrediction of Prophylactic Response to Lithium in Bipolar Disorder Using Acute Antidepressant Non-Response to Ketamine: A Scoping Review
Lithium remains the first choice for long-term prophylaxis of mood episodes in bipolar disorder (BD), but only 30% of patients will respond, and there is no reliable method by which to predict treatment response. Ketamine is a rapid antidepressant therapy which ostensibly yields greater results in patients with clinical phenotypes that are classically associated with lithium non-response. Thus, we hypothesized an inverse relationship between acute ketamine response and efficacy of long-term prophylactic lithium therapy in BD. We conducted a scoping review of clinical and preclinical studies that examine convergent and divergent predictors and mechanisms of acute response to ketamine and long-term response to lithium. Preclinical data show mechanistic convergence of ketamine and lithium on the GSK-3β/mTOR pathways, and enhancement of synaptic plasticity. Furthermore, lithium appears to consistently limit ketamine-related oxidative stress and hyperlocomotion. However, clinical predictors diverge, with ketamine response associated with metabolic risk factors, anxiety/mixed features, and non-melancholic presentations, which are generally predictors of poorer prophylactic lithium response. No study directly tested ketamine response as a predictor of prophylactic lithium response. An important limitation is that clinical studies of ketamine are enriched for lithium-refractory populations and have often included mixed unipolar and bipolar cases. Overall, existing data support mechanistic overlap but clinical divergence between ketamine and lithium responders, which is only partially consistent with our hypothesized inverse relationship. We must therefore undertake longitudinal studies of prophylactic lithium therapy among patients with BD who received ketamine for acute antidepressant treatment. If this inverse relationship is validated, ketamine non-response could be used to rapidly identify lithium-responsive BD, thereby establishing control over this disease earlier in the course of illness.
- Open Access
- 6 September 2025
- Published by Center for Open Science in PsyArXiv
The conceptualization, measurement, and critical appraisal of computational models of anhedonia in depression
Anhedonia, a cardinal feature of depressive disorders, is classically defined as an inability to experience pleasure, but modern definitions also encompass deficits in anticipatory pleasure and motivation. Validated scales and behavioural tasks have evolved alongside these conceptual shifts, and when integrated with computational modelling, may help reveal mechanisms underlying anhedonia. Reinforcement learning (RL) is the dominant computational framework for studying anhedonia, but fails to fully capture anticipation and motivation. We reviewed the operationalization and measurement of anhedonia from a historical perspective, and conducted a scoping review and critical appraisal of 19 computational models using a structured appraisal guide to assess face, construct and predictive validity. We focussed on generative models (i.e., models that can simulate behavioural data) that were paired with measures of anhedonia in both clinical and non-clinical samples. Model types include RL models, RL integrated with functional magnetic resonance imaging, and models of decision making, effort expenditure, and selective attention. Our review suggests that anhedonia-related deficits span not only reward processing, but also executive and sensory processing. Models generally demonstrated face validity, lacked predictive validity, and showed construct validity for cognitive-behavioural, but not neurobiological, domains. We propose an integrative, systems neuroscience-inspired approach, which aligns with multidimensional definitions of anhedonia.
- 6 September 2025
- Published by Center for Open Science in PsyArXiv
Open AccessThe conceptualization, measurement, and critical appraisal of computational models of anhedonia in depression
Anhedonia, a cardinal feature of depressive disorders, is classically defined as an inability to experience pleasure, but modern definitions also encompass deficits in anticipatory pleasure and motivation. Validated scales and behavioural tasks have evolved alongside these conceptual shifts, and when integrated with computational modelling, may help reveal mechanisms underlying anhedonia. Reinforcement learning (RL) is the dominant computational framework for studying anhedonia, but fails to fully capture anticipation and motivation. We reviewed the operationalization and measurement of anhedonia from a historical perspective, and conducted a scoping review and critical appraisal of 19 computational models using a structured appraisal guide to assess face, construct and predictive validity. We focussed on generative models (i.e., models that can simulate behavioural data) that were paired with measures of anhedonia in both clinical and non-clinical samples. Model types include RL models, RL integrated with functional magnetic resonance imaging, and models of decision making, effort expenditure, and selective attention. Our review suggests that anhedonia-related deficits span not only reward processing, but also executive and sensory processing. Models generally demonstrated face validity, lacked predictive validity, and showed construct validity for cognitive-behavioural, but not neurobiological, domains. We propose an integrative, systems neuroscience-inspired approach, which aligns with multidimensional definitions of anhedonia.
- Open Access
- 26 June 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (6) , e70303
A New Measure of Mnemonic Discrimination Applicable to Recognition Memory Tests With Continuous Variation in Novel Stimulus Interference
Background: Mnemonic discrimination (MD) involves distinguishing new stimuli from highly similar memories; it is impaired in the elderly and individuals with neuropsychiatric disorders and may also probe hippocampal dentate gyrus function. Measuring MD is, therefore, highly relevant; however, the gold‐standard MD test, the mnemonic similarity task (MST), is rarely used in clinical research. Thus, it would be useful to develop a novel MD index applicable to recognition memory tasks that are commonly used in clinical research. The present study develops such a measure and demonstrates its convergent validity with the gold‐standard MD index from the MST.Methods: We derived participant‐level indices of MD (λ) and overall recognition memory performance (Δ) by fitting a logistic function to the relationship between stimulus interference and the probability of classifying a stimulus as novel. We then applied these novel measures to two independent MST datasets (N = 18; N = 67) and to simulated MST data. We used linear mixed‐effects model to test whether (1) λ predicts the MST's MD measure, the lure discrimination index (LDI), and (2) Δ predicts the MST's overall recognition memory index (REC).Results: λ predicted LDI (β = 0.76, 95% CI [0.62, 0.91], p < 0.001) but not REC (β = 0.06, 95% CI [−0.03, 0.15], p = 0.197), while Δ predicted REC (β = 0.93, 95% CI [0.83, 1.02], p < 0.001) but not LDI (β = −0.06, 95% CI [−0.20, 0.09], p = 0.438). The λ and Δ indices were statistically independent, although simulations with synthetic data suggest that MD measurement may be compromised if overall recognition memory performance is impaired.Conclusion: We have developed a novel measure of MD applicable to two‐choice recognition memory tasks that use stimuli with continuously varying degrees of similarity. Future studies should further validate this measure using large clinical datasets that include both MD and other recognition memory tasks.
- 26 June 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (6) , e70303
Open AccessA New Measure of Mnemonic Discrimination Applicable to Recognition Memory Tests With Continuous Variation in Novel Stimulus Interference
Background: Mnemonic discrimination (MD) involves distinguishing new stimuli from highly similar memories; it is impaired in the elderly and individuals with neuropsychiatric disorders and may also probe hippocampal dentate gyrus function. Measuring MD is, therefore, highly relevant; however, the gold‐standard MD test, the mnemonic similarity task (MST), is rarely used in clinical research. Thus, it would be useful to develop a novel MD index applicable to recognition memory tasks that are commonly used in clinical research. The present study develops such a measure and demonstrates its convergent validity with the gold‐standard MD index from the MST.Methods: We derived participant‐level indices of MD (λ) and overall recognition memory performance (Δ) by fitting a logistic function to the relationship between stimulus interference and the probability of classifying a stimulus as novel. We then applied these novel measures to two independent MST datasets (N = 18; N = 67) and to simulated MST data. We used linear mixed‐effects model to test whether (1) λ predicts the MST's MD measure, the lure discrimination index (LDI), and (2) Δ predicts the MST's overall recognition memory index (REC).Results: λ predicted LDI (β = 0.76, 95% CI [0.62, 0.91], p < 0.001) but not REC (β = 0.06, 95% CI [−0.03, 0.15], p = 0.197), while Δ predicted REC (β = 0.93, 95% CI [0.83, 1.02], p < 0.001) but not LDI (β = −0.06, 95% CI [−0.20, 0.09], p = 0.438). The λ and Δ indices were statistically independent, although simulations with synthetic data suggest that MD measurement may be compromised if overall recognition memory performance is impaired.Conclusion: We have developed a novel measure of MD applicable to two‐choice recognition memory tasks that use stimuli with continuously varying degrees of similarity. Future studies should further validate this measure using large clinical datasets that include both MD and other recognition memory tasks.
- Open Access
- 6 March 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-7
Depersonalization and derealization as sequelae of a temporal lobe lesion: a case report
Background: Depersonalization and derealization can occur not just from psychiatric causes but also from various organic etiologies, such as seizures and intracerebral structural abnormalities. However, there have been no previous reported cases to the authors’ knowledge detailing isolated depersonalization and derealization in the absence of clinical seizure activity or other psychiatric pathology, as sequelae of structural intracerebral lesions. Case presentation: In this case report, we detail the unique presentation of a 68-year-old woman under the care of palliative medicine who experienced depersonalization and derealization secondary to a metastatic lesion in her temporal lobe, in the parahippocampal gyrus to medial occipitotemporal gyrus region. These symptoms were present in the absence of any clinical seizure activity or other psychiatric symptomatology and largely resolved with the use of steroidal therapy, before returning secondary to disease progression. Conclusions: We discuss the relationship among isolated depersonalization and derealization with pathology of the left posterior temporal lobe in the context of this interesting case. This case expands our knowledge of the neurobiology of these phenomena, given the specific localization of the intracerebral pathology and temporal specificity of symptoms relative to tumor growth and treatment course.
- 6 March 2024
- Published by Springer Nature in BMC Psychiatry
- Vol. 24 (1) , 1-7
Open AccessDepersonalization and derealization as sequelae of a temporal lobe lesion: a case report
Background: Depersonalization and derealization can occur not just from psychiatric causes but also from various organic etiologies, such as seizures and intracerebral structural abnormalities. However, there have been no previous reported cases to the authors’ knowledge detailing isolated depersonalization and derealization in the absence of clinical seizure activity or other psychiatric pathology, as sequelae of structural intracerebral lesions. Case presentation: In this case report, we detail the unique presentation of a 68-year-old woman under the care of palliative medicine who experienced depersonalization and derealization secondary to a metastatic lesion in her temporal lobe, in the parahippocampal gyrus to medial occipitotemporal gyrus region. These symptoms were present in the absence of any clinical seizure activity or other psychiatric symptomatology and largely resolved with the use of steroidal therapy, before returning secondary to disease progression. Conclusions: We discuss the relationship among isolated depersonalization and derealization with pathology of the left posterior temporal lobe in the context of this interesting case. This case expands our knowledge of the neurobiology of these phenomena, given the specific localization of the intracerebral pathology and temporal specificity of symptoms relative to tumor growth and treatment course.
- Open Access
- 14 November 2023
- Published by Center for Open Science in PsyArXiv
A New Measure of Mnemonic Discrimination Applicable to Recognition Memory Tests with Continuous Variation in Novel Stimulus Interference
Background: Mnemonic discrimination (MD) involves distinguishing new stimuli from memories of highly similar “lure” items or events, and is a putative indirect probe of dentate gyrus functioning. MD is impaired in the elderly and in individuals with hippocampal lesions, schizophrenia, major depressive disorder, and Alzheimer’s disease. The gold-standard MD test, called the mnemonic similarity task (MST), is rarely used in clinical research. We therefore aimed to validate a novel analysis method that extracts information about MD and recognition memory in widely clinically used recognition memory tests which do not have categorical distinctions between “lures” and “foils.”Methods: By fitting a logistic function to the relationship between stimulus interference and the probability of classifying a stimulus as novel, at the single participant level, we derived participant-level indices of MD (λ) and overall recognition memory performance (Δ). We applied the novel measures to MST data from two independent datasets (N=18; N=67). Using linear mixed-effects modelling, we sought to confirm that λ predicts the MST’s lure discrimination index (LDI), while Δ predicts the MST’s overall recognition memory index (REC). Results: Across both datasets, λ predicted LDI (β=0.76, 95% CI [0.62-0.91], p<0.001), but not REC (β=-0.06, 95% CI [-0.20-0.09], p=0.438), while Δ predicted REC (β=0.93, 95% CI [0.83-1.02], p<0.001), but not LDI (β=0.06, 95% CI [-0.03-0.15], p=0197). The λ and Δ indices were not correlated.Conclusion: Our novel measure accurately indexes MD, without correlating with overall recognition memory performance. Future studies should apply it to large clinical datasets with widely used recognition memory tests, such as the California Verbal Learning Test.
- 14 November 2023
- Published by Center for Open Science in PsyArXiv
Open AccessA New Measure of Mnemonic Discrimination Applicable to Recognition Memory Tests with Continuous Variation in Novel Stimulus Interference
Background: Mnemonic discrimination (MD) involves distinguishing new stimuli from memories of highly similar “lure” items or events, and is a putative indirect probe of dentate gyrus functioning. MD is impaired in the elderly and in individuals with hippocampal lesions, schizophrenia, major depressive disorder, and Alzheimer’s disease. The gold-standard MD test, called the mnemonic similarity task (MST), is rarely used in clinical research. We therefore aimed to validate a novel analysis method that extracts information about MD and recognition memory in widely clinically used recognition memory tests which do not have categorical distinctions between “lures” and “foils.”Methods: By fitting a logistic function to the relationship between stimulus interference and the probability of classifying a stimulus as novel, at the single participant level, we derived participant-level indices of MD (λ) and overall recognition memory performance (Δ). We applied the novel measures to MST data from two independent datasets (N=18; N=67). Using linear mixed-effects modelling, we sought to confirm that λ predicts the MST’s lure discrimination index (LDI), while Δ predicts the MST’s overall recognition memory index (REC). Results: Across both datasets, λ predicted LDI (β=0.76, 95% CI [0.62-0.91], p<0.001), but not REC (β=-0.06, 95% CI [-0.20-0.09], p=0.438), while Δ predicted REC (β=0.93, 95% CI [0.83-1.02], p<0.001), but not LDI (β=0.06, 95% CI [-0.03-0.15], p=0197). The λ and Δ indices were not correlated.Conclusion: Our novel measure accurately indexes MD, without correlating with overall recognition memory performance. Future studies should apply it to large clinical datasets with widely used recognition memory tests, such as the California Verbal Learning Test.
- Top Cited PapersOpen Access
Scoping review to evaluate the effects of peer support on the mental health of young adults
Objectives Young adults report disproportionality greater mental health problems compared with the rest of the population with numerous barriers preventing them from seeking help. Peer support, defined as a form of social-emotional support offered by an individual with a shared lived experience, has been reported as being effective in improving a variety of mental health outcomes in differing populations. The objective of this scoping review is to provide an overview of the literature investigating the impact of peer support on the mental health of young adults. Design A scoping review methodology was used to identify relevant peer-reviewed articles in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines across six databases and Google/Google Scholar. Overall, 17 eligible studies met the inclusion criteria and were included in the review. Results Overall, studies suggest that peer support is associated with improvements in mental health including greater happiness, self-esteem and effective coping, and reductions in depression, loneliness and anxiety. This effect appears to be present among university students, non-student young adults and ethnic/sexual minorities. Both individual and group peer support appear to be beneficial for mental health with positive effects also being present for those providing the support. Conclusions Peer support appears to be a promising avenue towards improving the mental health of young adults, with lower barriers to accessing these services when compared with traditional mental health services. The importance of training peer supporters and the differential impact of peer support based on the method of delivery should be investigated in future research.
Top Cited PapersOpen AccessScoping review to evaluate the effects of peer support on the mental health of young adults
Objectives Young adults report disproportionality greater mental health problems compared with the rest of the population with numerous barriers preventing them from seeking help. Peer support, defined as a form of social-emotional support offered by an individual with a shared lived experience, has been reported as being effective in improving a variety of mental health outcomes in differing populations. The objective of this scoping review is to provide an overview of the literature investigating the impact of peer support on the mental health of young adults. Design A scoping review methodology was used to identify relevant peer-reviewed articles in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines across six databases and Google/Google Scholar. Overall, 17 eligible studies met the inclusion criteria and were included in the review. Results Overall, studies suggest that peer support is associated with improvements in mental health including greater happiness, self-esteem and effective coping, and reductions in depression, loneliness and anxiety. This effect appears to be present among university students, non-student young adults and ethnic/sexual minorities. Both individual and group peer support appear to be beneficial for mental health with positive effects also being present for those providing the support. Conclusions Peer support appears to be a promising avenue towards improving the mental health of young adults, with lower barriers to accessing these services when compared with traditional mental health services. The importance of training peer supporters and the differential impact of peer support based on the method of delivery should be investigated in future research.
- Open Access
Sleep, biological rhythms and anxiety in the perinatal period: a systematic review protocol
Introduction Pregnancy and new parenthood is an exciting time, but also a stressful life event that can predispose to mental health challenges. Perinatal anxiety is one such challenge, and is an important contributor to parental distress and other negative outcomes. Sleep and biological rhythms are often disrupted in the perinatal period. These disruptions have been associated with postpartum depression, and in some cases with perinatal anxiety. However, the literature concerning the association with perinatal anxiety is inconsistent and may be methodologically limited. To our knowledge, there has been no comprehensive review published characterising the relationships between sleep, biological rhythms, and perinatal anxiety and related disorders to date. In this systematic review, we will summarise the current state of the literature concerning these relationships, allowing us to highlight gaps and potentially inform clinical understanding of perinatal anxiety, sleep and biological rhythms. Methods and analysis Primary research articles will be eligible for inclusion if they assess perinatal anxiety or related disorders using validated criteria (self-report or diagnostic), assess sleep and biological rhythms in the perinatal period, include >4 participants and meet other inclusion/exclusion criteria. We will conduct comprehensive searches of MEDLINE, PsycINFO, Embase and CINAHL, with coverage spanning from database conception to search date (August 1, 2021). Key search concepts include (1) the perinatal period, (2) sleep/biological rhythms and (3) anxiety. Risk of bias will be evaluated using the Cochrane Risk of Bias Tool. Data will be narratively synthesised, with quantitative synthesis included if possible. When relevant, strength of evidence will be assessed using Grading of Recommendations Assessment, Development and Evaluation criteria, and potential publication bias will be assessed. Ethics and dissemination Research ethics approval is not required. Study results will be reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Results will be disseminated to relevant stakeholders as conference presentation(s) and submitted for publication in a peer-reviewed journal. PROSPERO registration number 200166.
Open AccessSleep, biological rhythms and anxiety in the perinatal period: a systematic review protocol
Introduction Pregnancy and new parenthood is an exciting time, but also a stressful life event that can predispose to mental health challenges. Perinatal anxiety is one such challenge, and is an important contributor to parental distress and other negative outcomes. Sleep and biological rhythms are often disrupted in the perinatal period. These disruptions have been associated with postpartum depression, and in some cases with perinatal anxiety. However, the literature concerning the association with perinatal anxiety is inconsistent and may be methodologically limited. To our knowledge, there has been no comprehensive review published characterising the relationships between sleep, biological rhythms, and perinatal anxiety and related disorders to date. In this systematic review, we will summarise the current state of the literature concerning these relationships, allowing us to highlight gaps and potentially inform clinical understanding of perinatal anxiety, sleep and biological rhythms. Methods and analysis Primary research articles will be eligible for inclusion if they assess perinatal anxiety or related disorders using validated criteria (self-report or diagnostic), assess sleep and biological rhythms in the perinatal period, include >4 participants and meet other inclusion/exclusion criteria. We will conduct comprehensive searches of MEDLINE, PsycINFO, Embase and CINAHL, with coverage spanning from database conception to search date (August 1, 2021). Key search concepts include (1) the perinatal period, (2) sleep/biological rhythms and (3) anxiety. Risk of bias will be evaluated using the Cochrane Risk of Bias Tool. Data will be narratively synthesised, with quantitative synthesis included if possible. When relevant, strength of evidence will be assessed using Grading of Recommendations Assessment, Development and Evaluation criteria, and potential publication bias will be assessed. Ethics and dissemination Research ethics approval is not required. Study results will be reported according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Results will be disseminated to relevant stakeholders as conference presentation(s) and submitted for publication in a peer-reviewed journal. PROSPERO registration number 200166.
- Open Access
- 18 February 2021
- Published by Springer Nature in Environmental Health
- Vol. 20 (1) , 1-10
Fluoride exposure and duration and quality of sleep in a Canadian population-based sample
Background: Fluoride from dietary and environmental sources may concentrate in calcium-containing regions of the body such as the pineal gland. The pineal gland synthesizes melatonin, a hormone that regulates the sleep-wake cycle. We examined associations between fluoride exposure and sleep outcomes among older adolescents and adults in Canada. Methods: We used population-based data from Cycle 3 (2012–2013) of the Canadian Health Measures Survey. Participants were aged 16 to 79 years and 32% lived in communities supplied with fluoridated municipal water. Urinary fluoride concentrations were measured in spot samples and adjusted for specific gravity (UFSG; n = 1303) and water fluoride concentrations were measured in tap water samples among those who reported drinking tap water (n = 1016). We used multinomial and ordered logistic regression analyses (using both unweighted and survey-weighted data) to examine associations of fluoride exposure with self-reported sleep outcomes, including sleep duration, frequency of sleep problems, and daytime sleepiness. Covariates included age, sex, ethnicity, body mass index, chronic health conditions, and household income. Results: Median (IQR) UFSG concentration was 0.67 (0.63) mg/L. Median (IQR) water fluoride concentration was 0.58 (0.27) mg/L among participants living in communities supplied with fluoridated municipal water and 0.01 (0.06) mg/L among those living in non-fluoridated communities. A 0.5 mg/L higher water fluoride level was associated with 34% higher relative risk of reporting sleeping less than the recommended duration for age [unweighted: RRR = 1.34, 95% CI: 1.03, 1.73; p = .026]; the relative risk was higher, though less precise, using survey-weighted data [RRR = 1.96, 95% CI: 0.99, 3.87; p = .05]. UFSG was not significantly associated with sleep duration. Water fluoride and UFSG concentration were not significantly associated with frequency of sleep problems or daytime sleepiness. Conclusions: Fluoride exposure may contribute to sleeping less than the recommended duration among older adolescents and adults in Canada.
- 18 February 2021
- Published by Springer Nature in Environmental Health
- Vol. 20 (1) , 1-10
Open AccessFluoride exposure and duration and quality of sleep in a Canadian population-based sample
Background: Fluoride from dietary and environmental sources may concentrate in calcium-containing regions of the body such as the pineal gland. The pineal gland synthesizes melatonin, a hormone that regulates the sleep-wake cycle. We examined associations between fluoride exposure and sleep outcomes among older adolescents and adults in Canada. Methods: We used population-based data from Cycle 3 (2012–2013) of the Canadian Health Measures Survey. Participants were aged 16 to 79 years and 32% lived in communities supplied with fluoridated municipal water. Urinary fluoride concentrations were measured in spot samples and adjusted for specific gravity (UFSG; n = 1303) and water fluoride concentrations were measured in tap water samples among those who reported drinking tap water (n = 1016). We used multinomial and ordered logistic regression analyses (using both unweighted and survey-weighted data) to examine associations of fluoride exposure with self-reported sleep outcomes, including sleep duration, frequency of sleep problems, and daytime sleepiness. Covariates included age, sex, ethnicity, body mass index, chronic health conditions, and household income. Results: Median (IQR) UFSG concentration was 0.67 (0.63) mg/L. Median (IQR) water fluoride concentration was 0.58 (0.27) mg/L among participants living in communities supplied with fluoridated municipal water and 0.01 (0.06) mg/L among those living in non-fluoridated communities. A 0.5 mg/L higher water fluoride level was associated with 34% higher relative risk of reporting sleeping less than the recommended duration for age [unweighted: RRR = 1.34, 95% CI: 1.03, 1.73; p = .026]; the relative risk was higher, though less precise, using survey-weighted data [RRR = 1.96, 95% CI: 0.99, 3.87; p = .05]. UFSG was not significantly associated with sleep duration. Water fluoride and UFSG concentration were not significantly associated with frequency of sleep problems or daytime sleepiness. Conclusions: Fluoride exposure may contribute to sleeping less than the recommended duration among older adolescents and adults in Canada.